Zobrazeno 1 - 10
of 30
pro vyhledávání: '"N M, Vorob'eva"'
Autor:
O. N. Tkacheva, N. M. Vorob’eva, Yu. V. Kotovskaya, O. D. Ostroumova, M. S. Chernyaeva, M. V. Silyutina, A. V. Chernov, S. G. Testova, L. N. Ovcharova, E. V. Selezneva
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 10 (2020)
Aim. To study the prevalence of geriatric syndromes and assess their relationship with senile asthenia in persons aged ³65 years living in Russian regions with different demographic, climatic and socio-economic characteristics.Material and methods.
Externí odkaz:
https://doaj.org/article/e1c5f8fb9377442f9eeb9de4fecffb5a
Autor:
N M Vorob'eva, O V Ermolina, T V Balakhonova, A B Dobrovol'skiĭ, E V Titaeva, A I Kirienko, E P Panchenko
Publikováno v:
Терапевтический архив, Vol 80, Iss 7, Pp 50-54 (2008)
Aim. To evaluate efficacy of 3 month therapy with warfarin in patients after an episode of deep vein thrombosis (DVT) and/or pulmonary artery thromboembolism (PATE), safety of the treatment. Material and methods. 26patients after DVT/PATE aged 18-74
Externí odkaz:
https://doaj.org/article/23558ee27dab4143934e4b54bfb432f4
Autor:
Yu. V. Kotovskaya, E. V. Selezneva, N. M. Vorob’eva, M. S. Chernyaeva, A. V. Chernov, Olga D. Ostroumova, Olga N. Tkacheva, L. N. Ovcharova, M. V. Silyutina, S. G. Testova
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 10 (2020)
Aim.To study the prevalence of geriatric syndromes and assess their relationship with senile asthenia in persons aged ³65 years living in Russian regions with different demographic, climatic and socio-economic characteristics.Material and methods.We
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, O V, Ermolina, T V, Balakhonova, Z B, Khasanova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(12)
To study effects of thrombin-activated fibrinolysis inhibitor (TAFI) on efficacy and safety of long-term anti-coagulant treatment in patients with venous thromboembolic complications (VTEC).A total of 111 patients with a history of an episode of deep
Autor:
N M, Vorob'eva, E P, Panchenko, O V, Ermolina, T V, Balakhonova, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(8)
To compare effects of prolongation of the treatment with therapeutic doses of enoxaparin to 1 month on recanalization of occlusively thrombosed deep veins (OTDV) of the limbs with results of standard therapy with unfractionated heparin (UFH). Both tr
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, N V, Konovalova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(6)
To investigate frequency of carriage of genetic polymorphisms CYP2C9 and VKORC1 in patients with venous thromboembolic complications (VTEC) in Moscow population given warfarin treatment and effects of this carriage on stability of anticoagulation and
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, O V, Ermolina, T V, Balakhonova, A I, Kirienko
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 17(1)
The study was aimed at comparing efficacy and safety of two diferent approaches to initial anticoagulant therapy: a standard approach (non-fractionated heparin [NFH]for not less than 5 days followed by changing over to warfarin) and an alternative on
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, N V, Konovalova, A Iu, Postnov, O V, Ermolina, T V, Balakhonova, A I, Kirienko
Publikováno v:
Kardiologiia. 50(12)
We followed for 18 months 90 patients who had had deep vein thrombosis (DVE) and/or pulmonary embolism (PE) and received therapy with anticoagulants either for 3-12 months or for indefinitely long time. During follow-up rate of recurrent DVE was 16.7
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 16(4)
To study the factors associated with an elevated content of D-dimer in patients diagnosed as having cardiovascular diseases (CVD) with no apparent thromboembolic complications.A retrospective analysis of 1,000 case histories of patients (624 men and
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, Iu A, Fedotkina, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 82(8)
to study the prevalence of various risk factors (RF) for venous thromboembolic events (VTEE) and their association with D-dimer levels.The clinical, demographic, anthropometric, anamnestic, and laboratory data were analyzed in 106 patients (73 men an